Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Clinical Trial of Neoadjuvant Tivozanib in Localized Renal Cell Carcinoma

NCT01769885 is registered in ClinicalTrials.gov with Roswell Park Cancer Institute as lead sponsor.

NCT NCT01769885
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01769885 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Clinical Trial of Neoadjuvant Tivozanib in Localized Renal Cell Carcinoma
Lead sponsor
Roswell Park Cancer Institute
Phase
Not applicable
Overall status
Withdrawn
Start date
March 14, 2013
Completion date
December 2, 2013
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

stage ii renal cell cancer, stage iii renal cell cancer